Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (4) | Back to Search
Proper use of linezolid in a teaching hospital: assessment of one year of pharmaceutical controlled distribution system
- In: Poster presentation
- At: Buenos Aires (Argentina) (2016)
- Type: Poster
- Poster code: POS-HPS-005
- By: BIDON, Doriane (Pitié-Salpêtrière hospital, Pharmacy, PARIS, France)
- Co-author(s): Doriane BIDON:Pharmacy,Pitié-Salpêtrière hospital,PARIS,France|Raphaelle PESQUE:Pharmacy,Pitié-Salpêtrière hospital,PARIS,France|Carole METZ:Pharmacy,Pitié-Salpêtrière hospital,PARIS,France|Marie-Hélène FIEVET:Pharmacy,Pitié-Salpêtrière hospital,PARIS,France|Helga JUNOT:Pharmacy,Pitié-Salpêtrière hospital,PARIS,France
- Abstract:
Linezolid (LNZ), an oxazolidinone antibiotic active against Gram-positive bacteria, is prescribed as an alternative to glycopeptide antibiotics and may be prescribed in resistant tuberculosis. In order to prevent emergence of resistance, local guidelines have been established.
Patient data treated with LNZ were collected by the pharmacy
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023